SFPIA
FOLD

Stevens First Principles Investment Advisors’s Amicus Therapeutics FOLD Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-400
Closed -$3K – 215
2014
Q4 		$3K Sell
400
-100
-20% -$686 ﹤0.01% 204
2014
Q3 		$3K Buy
+500
New +$2.62K ﹤0.01% 220

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stevens First Principles Investment Advisors's FOLD Position: Q1 2015 in Review

Stevens First Principles Investment Advisors sold out of Amicus Therapeutics (FOLD) in Q1 2015, closing a stake of 400 shares — an estimated $3K sold.

Stevens First Principles Investment Advisors first reported a position in FOLD in Q3 2014 and held it in 2 quarters. The position peaked at $3K in Q4 2014. 125 funds tracked by Wall St. Rank hold FOLD as of Q1 2015.

  • Stevens First Principles Investment Advisors reported no remaining Amicus Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 400 Amicus Therapeutics shares in Q1 2015, an estimated $3K.
  • Stevens First Principles Investment Advisors first reported a position in Amicus Therapeutics in Q3 2014 and held it in 2 quarters.
  • Stevens First Principles Investment Advisors's Amicus Therapeutics position peaked at $3K in Q4 2014.
  • 125 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2015.

Based on Stevens First Principles Investment Advisors's 13F filing for Q1 2015, filed 7 May 2015.